ZIIHERA

ZANIDATAMAB-HRII · Jazz Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ZIIHERA, covering 2024-11-20 to 2026-08-25. Get the full timeline:

Most recent: FDA Approved: ZIIHERA — Supplemental Application (Jazz Pharmaceuticals, Inc.)